ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Bausch Health makes $200m bid for bankrupt Synergy Pharmaceuticals
pharmaceutical-technology
December 17, 2018Canada-based Bausch Health Companies (previously Valeant Pharmaceuticals) has entered a definitive agreement to acquire select assets of Synergy Pharmaceuticals for around $200m and certain assumed liabilities..... -
Bausch Health buy bankrupt Synergy Pharmaceuticals for $200m
pharmafile
December 14, 2018Bankrupt drug developer Synergy Pharmaceuticals has announced that the company is to be acquired by Canadian speciality pharma firm Bausch Health for approximately $200 million in cash. -
Synergy Pharmaceuticals inks deal with Luxion Pharma
biospectrumasia
August 13, 2018The deal gives Luoxin exclusive rights to develop and commercialize Synergy’s lead product TRULANCE (plecanatide) for the treatment of adults with chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C) in mainland Chi
Pharma Sources Insight January 2025
